Gender differences in the risk of stroke during support with continuous-flow left ventricular assist device

Journal of Heart and Lung Transplantation

Volumn 34, Issue 12, 2015, Pages 1570-1577

  Morris, Alanna A ^a   Pekarek, Ann ^a   Wittersheim, Kris ^a   Cole, Robert T ^a   Gupta, Divya ^a   Nguyen, Duc ^a   Laskar, S Raja ^a   Butler, Javed ^a   Smith, Andrew ^a   Vega, J David ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

gender; healthcare disparities; heart failure; left ventricular assist device; prognosis; risk factors; stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIBIOTIC AGENT; WARFARIN;

ADULT; ANTIBIOTIC THERAPY; ANTICOAGULANT THERAPY; ARTICLE; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIAC PATIENT; CEREBROVASCULAR ACCIDENT; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; DEVICE INFECTION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; THROMBOSIS; ADVERSE EFFECTS; COMPARATIVE STUDY; HEART ASSIST DEVICE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; SEX RATIO; STROKE;

FEMALE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; STROKE;

EID: 84949761113     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2015.08.013     Document Type: Article

References (39)

1. M. Colvin-Adams, J.M. Smith, B.M. Heubner, and et al. OPTN/SRTR 2011 annual data: Heart Am J Transplant 13 2013 119 148
2. J.K. Kirklin, D.C. Naftel, R.L. Kormos, and et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients J Heart Lung Transplant 32 2013 141 156
3. E.A. Rose, A.C. Gelijns, A.J. Moskowitz, and et al. Long-term use of a left ventricular assist device for end-stage heart failure N Engl J Med 345 2001 1435 1443
4. J.W. Long, A.G. Kfoury, M.S. Slaughter, and et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study Congest Heart Failure 11 2005 133 138
5. M.S. Slaughter, J.G. Rogers, C.A. Milano, and et al. Advanced heart failure treated with continuous-flow left ventricular assist device N Engl J Med 361 2009 2241 2251
6. J.G. Rogers, K.D. Aaronson, A.J. Boyle, and et al. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients J Am Coll Cardiol 55 2010 1826 1834
7. M.R. Mehra, and M.J. Domanski Should left ventricular assist device be standard of care for patients with refractory heart failure who are not transplantation candidates? Circulation 126 2012 3081 3087
8. J.G. Rogers, J. Butler, S.L. Lansman, and et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial J Am Coll Cardiol 50 2007 741 747
9. M.C. Bunte, E.H. Blackstone, L. Thuita, and et al. Major bleeding during HeartMate II support J Am Coll Cardiol 62 2013 2188 2196
10. A.J. Boyle, U.P. Jorde, B. Sun, and et al. Pre-operative risk factors of bleeding and stroke during left ventricular assist device support: an analysis of more than 900 HeartMate II outpatients J Am Coll Cardiol 63 2014 880 888
11. E.M. Hsich, D.C. Naftel, S.L. Myers, and et al. Should women receive left ventricular assist device support? findings from INTERMACS Circulation 5 2012 234 240
12. R.C. Bogaev, S.V. Pamboukian, S.A. Moore, and et al. Comparison of outcomes in women versus men using a continuous-flow left ventricular assist device as a bridge to transplantation J Heart Lung Transplant 30 2011 515 522
13. INTERMACS Working Group. Manual of operations for the Interagency Registry for Mechanically Assisted Circulatory Support: adverse events criteria (version 3.0). http://www.uab.edu/medicine/intermacs/appendices/appendix-a/. Accessed May 25, 2014.
14. F. Rosendaal, S. Cannegieter, F.J. van der Meer, and et al. A method to determine the optimal intensity of oral anticoagulant therapy Thromb Haemostasis 69 1993 236 239
15. J.P. Fine, and R.J. Gray A proportional hazards model for the subdistribution of a competing risk J Am Stat Assoc 94 1999 496 509
16. B.F. Gage, A.B. Cardinalli, and D.K. Owens The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life Arch Intern Med 156 1996 1829 1836
17. M.T.M. Lee, and T.E. Klein Pharmacogenetics of warfarin: challenges and opportunities J Hum Genet 58 2013 334 338
18. M.R. Patel, K.W. Mahaffey, J. Garg, and et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 2011 883 891
19. SPORTIF Executive Steering Committee for the SPORTIF V Investigators Ximelagatran vs warfarin for stroke prevention in patients with nonvalvular atrial fibrillation: a randomized trial JAMA 293 2005 690 698
20. S.J. Connolly, M.D. Ezekowitz, S. Yusuf, and et al. Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 2009 1139 1151
21. A.J. Rose, E.M. Hylek, A. Ozonoff, and et al. Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA) Circulation 4 2011 22 29
22. C.B. Granger, J.H. Alexander, J.J.V. McMurray, and et al. Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 2011 981 992
23. J.W. Eikelboom, S.J. Connolly, M. Brueckmann, and et al. Dabigatran versus warfarin in patients with mechanical heart valves N Engl J Med 369 2013 1206 1214
24. B.F. Gage, A.D. Waterman, W. Shannon, and et al. Validation of clinical classification schemes for predicting stroke: results from the national registry of atrial fibrillation JAMA 285 2001 2864 2870
25. M.A. Tsadok, C.A. Jackevicius, E. Rahme, and et al. Sex differences in stroke risk among older patients with recently diagnosed atrial fibrillation JAMA 307 2012 1952 1958
26. M.J. O'Donnell, D. Xavier, L. Liu, and et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study Lancet 376 2010 112 123
27. J. Hsia, K.L. Margolis, C.B. Eaton, and et al. Prehypertension and cardiovascular disease risk in the women's health initiative Circulation 115 2007 855 860
28. B. Boden-Albala, R.L. Sacco, H.-S. Lee, and et al. Metabolic syndrome and ischemic stroke risk: Northern Manhattan Study Stroke 39 2008 30 35
29. J.K. Ninomiya, G. L'Italien, M.H. Criqui, and et al. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey Circulation 109 2004 42 46
30. C. Bushnell, L.D. McCullough, I.A. Awad, and et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke 45 2014 1545 1588
31. W.D. Rosamond, A.R. Folsom, L.E. Chambless, and et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort Stroke 30 1999 736 743
32. P. Appelros, B. Stegmayr, and A. Tervent Sex differences in stroke epidemiology: a systematic review Stroke 40 2009 1082 1090
33. E. Lanzarone, F. Gelmini, M. Tessari, and et al. Preservation of endothelium nitric oxide release by pulsatile flow cardiopulmonary bypass when compared with continuous flow Artif Org 33 2009 926 934
34. R.P. White, P. Vallance, and H.S. Markus Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans Clin Sci 99 2000 555 560
35. W.K. Cornwell 3rd, T. Tarumi, V.L. Aengevaeren, and et al. The effect of pulsatile and nonpulsatile flow on cerebral perfusion in patients with LVADs J Heart Lung Transplant 33 2014 1295 1303
36. B.C. Lampert, C. Eckert, S. Weaver, and et al. Blood pressure control in continuous flow left ventricular assist devices: efficacy and impact on adverse events Ann Thorac Surg 97 2014 139 146
37. K.D. Aaronson, M.S. Slaughter, L.W. Miller, and et al. Use of an intrapericardial, continuous-flow, centrifugal pump in patients awaiting heart transplantation Circulation 125 2012 3191 3200
38. M.S. Slaughter, F.D. Pagani, E.C. McGee, and et al. HeartWare ventricular assist system for bridge to transplant: combined results of the bridge to transplant and continued access protocol trial J Heart Lung Transplant 32 2013 675 683
39. S.S. Najjar, M.S. Slaughter, F.D. Pagani, and et al. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial J Heart Lung Transplant 33 2014 23 34